| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,846,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,259,821 |
|
|
|
Indirect Value
|
$148,965,006 |
|
|
| Total
Shares |
10,589,900 |
|
|
| Total
Value |
$150,224,827 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-11-07 |
4 |
S |
$44.75 |
$1,790,000 |
I/I |
(40,000) |
49,394 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2020-10-14 |
4 |
B |
$19.00 |
$1,814,500 |
I/I |
95,500 |
4,370,496 |
2.66 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-08-01 |
4 |
OE |
$16.44 |
$1,972,500 |
D/D |
120,000 |
638,581 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-02-08 |
4 |
OE |
$8.94 |
$2,089,250 |
D/D |
170,000 |
1,221,553 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2007-05-02 |
4 |
OE |
$17.89 |
$2,146,200 |
D/D |
120,000 |
645,381 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2003-08-28 |
4 |
S |
$62.55 |
$2,191,850 |
D/D |
(35,000) |
182,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-07-24 |
4 |
OE |
$16.01 |
$2,241,400 |
D/D |
140,000 |
1,230,604 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-11-12 |
4 |
S |
$46.91 |
$2,252,446 |
D/D |
(47,920) |
1,032,236 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-04-30 |
4 |
OE |
$15.27 |
$2,289,750 |
D/D |
150,000 |
1,225,733 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-07-24 |
4 |
OE |
$15.27 |
$2,289,750 |
D/D |
150,000 |
1,226,525 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-11-07 |
4 |
OE |
$15.27 |
$2,289,750 |
D/D |
150,000 |
1,226,525 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2007-02-09 |
4 |
OE |
$16.44 |
$2,301,250 |
D/D |
140,000 |
659,301 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-10-25 |
4 |
OE |
$17.89 |
$2,503,900 |
D/D |
140,000 |
659,301 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-02-04 |
4 |
OE |
$15.27 |
$2,662,645 |
D/D |
173,452 |
1,249,977 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2020-10-14 |
4 |
A |
$0.00 |
$2,999,992 |
I/I |
3,208,835 |
263,750 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-10-25 |
4 |
S |
$67.20 |
$3,029,177 |
D/D |
(45,000) |
614,301 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-02-05 |
4 |
S |
$56.00 |
$3,035,200 |
D/D |
(54,200) |
190,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2003-11-25 |
4 |
S |
$58.00 |
$3,194,000 |
D/D |
(55,000) |
182,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2003-08-05 |
4 |
S |
$62.56 |
$3,483,530 |
D/D |
(55,020) |
182,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-04-30 |
4 |
S |
$52.10 |
$3,658,304 |
D/D |
(70,184) |
1,075,733 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2016-02-16 |
4 |
D |
$91.15 |
$3,711,263 |
D/D |
(40,716) |
191,940 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-05-05 |
4 |
S |
$58.30 |
$3,790,400 |
D/D |
(65,000) |
202,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-08-11 |
4 |
S |
$65.52 |
$3,936,875 |
D/D |
(60,000) |
207,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-04-30 |
4 |
S |
$52.00 |
$4,154,278 |
D/D |
(79,816) |
1,145,917 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-05-21 |
4 |
S |
$42.61 |
$4,260,880 |
D/D |
(100,000) |
1,090,125 |
0 |
- |
|
193 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
